Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07TDV
|
|||
| Former ID |
DNCL001844
|
|||
| Drug Name |
Bendavia
|
|||
| Synonyms |
Elamipretide
Click to Show/Hide
|
|||
| Indication | Mitochondrial myopathy [ICD-11: 8C73; ICD-10: G71.3] | Phase 3 | [1] | |
| Acute myocardial infarction [ICD-11: BA41; ICD-9: 410] | Phase 2 | [2] | ||
| Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [3] | ||
| Company |
Stealth Peptides
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C32H49N9O5
|
|||
| Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O
|
|||
| InChI |
1S/C32H49N9O5/c1-19-15-22(42)16-20(2)23(19)18-27(41-29(44)24(34)11-8-14-38-32(36)37)31(46)39-25(12-6-7-13-33)30(45)40-26(28(35)43)17-21-9-4-3-5-10-21/h3-5,9-10,15-16,24-27,42H,6-8,11-14,17-18,33-34H2,1-2H3,(H2,35,43)(H,39,46)(H,40,45)(H,41,44)(H4,36,37,38)/t24-,25+,26+,27+/m1/s1
|
|||
| InChIKey |
SFVLTCAESLKEHH-WKAQUBQDSA-N
|
|||
| CAS Number |
CAS 736992-21-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01572909) Evaluation of Myocardial Effects of Bendavia for Reducing Reperfusion Injury in Patients With Acute Coronary Events. U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.